Radiopharmaceut icals Market
Radiopharmaceuticals Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Radiopharmaceuticals Market Size and Growth
The radiopharmaceuticals market is experiencing robust growth, driven by increasing demand for diagnostic imaging and targeted therapies. The global market size was valued at approximately USD 6.9 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of around 8.5% through the following years.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Bracco Imaging
◍ Bayer
◍ Mallinckrodt
◍ Nordion
◍ Triad Isotopes
◍ Lantheus
◍ IBA Group
◍ GE Healthcare
◍ China Isotope & Radiation
◍ Jubilant Pharma
◍ Eli Lilly
◍ Advanced Accelerator Applications
◍ SIEMENS
◍ Dongcheng
◍ Navidea
The radiopharmaceuticals market features key players like Bracco Imaging, Bayer, and GE Healthcare, focusing on innovative diagnostics and therapeutics. Companies enhance market growth through new product development, strategic partnerships, and expanding applications in oncology. Sales revenues include:
- Bayer: ~$44 billion
- GE Healthcare: ~$19 billion
- Lantheus: ~$259 million
Request Sample Report
Market Segmentation
By Application
Oncology
Cardiology
Request Sample Report
By Product
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Market Growth
Request Sample Report
$ X Billion USD
